What oral decongestants are available, including recommended dosing and contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Decongestants: Available Agents, Dosing, and Contraindications

The two primary oral decongestants available are pseudoephedrine and phenylephrine, though pseudoephedrine is significantly more effective while phenylephrine's efficacy as an oral decongestant remains poorly established due to extensive first-pass metabolism. 1

Available Oral Decongestants

Pseudoephedrine

  • Most effective oral decongestant for relieving nasal congestion in both allergic and nonallergic rhinitis 1
  • Dosing: Typically available in 30 mg, 60 mg tablets; extended-release formulations allow longer dosing intervals
  • Availability: Now kept behind pharmacy counters due to methamphetamine production concerns, requiring identification for purchase 1

Phenylephrine

  • Questionable efficacy: Extensively metabolized in the gut with poor bioavailability at currently recommended doses 1
  • Substituted for pseudoephedrine in many OTC products due to regulatory restrictions
  • The efficacy of phenylephrine as an oral decongestant has not been well established 1

Phenylpropanolamine (Historical)

  • No longer available on the market due to FDA warning about adverse effects in 2005 2
  • Previously used but withdrawn from use

Mechanism and Clinical Use

Oral decongestants work as α-adrenergic agonists causing vasoconstriction to relieve nasal congestion 1. They are effective for both allergic and nonallergic rhinitis, including upper respiratory infections 1.

Important clinical note: The combination of oral decongestants with antihistamines has not been adequately documented to increase efficacy beyond either drug alone 1. Guidelines suggest not using oral decongestants regularly but consider them for rescue or as-needed medication 3.

Contraindications and Precautions

Absolute Cautions (Use with extreme caution or avoid):

  • Cardiovascular disease: Cerebrovascular disease, angina pectoris, cardiac arrhythmias 1
  • Uncontrolled hypertension 1
  • Hyperthyroidism 1
  • Closed-angle glaucoma 1
  • Bladder neck obstruction/prostatic hypertrophy 1

Blood Pressure Effects:

  • Normotensive patients: Elevation very rarely noted 1
  • Controlled hypertension: Only occasionally see elevation, but patients should be monitored due to individual variation 1
  • Pseudoephedrine causes small increases: systolic BP +0.99 mmHg, heart rate +2.83 beats/min 1

Age-Specific Considerations:

Children under 6 years:

  • Risks must be carefully weighed - associated with agitated psychosis, ataxia, hallucinations, and even death in infants and young children 1
  • May cause tachyarrhythmias, insomnia, hyperactivity even at recommended doses 1

Children over 6 years:

  • Usually very well tolerated at appropriate doses 1

Older adults:

  • Use with caution 1

Common Adverse Effects

  • Insomnia
  • Loss of appetite
  • Irritability
  • Palpitations
  • Tremor
  • Sleep disturbance 1

Drug interactions: Concomitant use with caffeine and stimulants (e.g., ADHD medications) may increase adverse effects additively 1

Clinical Recommendations

For adults with nasal congestion: Pseudoephedrine can be used as needed for symptom relief, monitoring blood pressure in hypertensive patients 1. The evidence suggests a small positive effect with multiple doses, though clinical relevance is uncertain 4.

Avoid regular daily use: Guidelines conditionally recommend against regular administration, placing higher value on avoiding adverse effects than on the small symptom reduction benefit 3.

For children under 6 years: The substantial safety concerns outweigh potential benefits in this population 1.

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

Oral antihistamine-decongestant-analgesic combinations for the common cold.

The Cochrane database of systematic reviews, 2022

Guideline

allergic rhinitis and its impact on asthma (aria) guidelines: 2010 revision.

Journal of Allergy and Clinical Immunology, 2010

Research

Nasal decongestants in monotherapy for the common cold.

The Cochrane database of systematic reviews, 2016

Related Questions

Are there prescription-strength decongestants available?
What oral nasal decongestant medications are available in pill form?
Which antihistamines can be safely combined, and what are the recommended dosing limits?
What are the recommendations for using decongestants (e.g. pseudoephedrine, phenylephrine) in patients with nasal congestion, considering factors such as age, medical history (e.g. hypertension, diabetes, thyroid disease), and potential side effects?
What are some name brand topical decongestants?
What is the maximum number of Imodium (loperamide) doses per day for adults and for children aged 2–12 years?
A male patient on testosterone therapy reports flushing; what is the likely cause and how should it be evaluated and managed?
What is the recommended initial psychiatric evaluation and treatment plan for an adult presenting with both attention‑deficit/hyperactivity disorder (ADHD) and generalized anxiety disorder (GAD)?
In a patient with stage IV chronic kidney disease, hyperchloremia, and a serum bicarbonate (CO₂) of 10 mEq/L who has just been started on sodium bicarbonate, what is the preferred intravenous fluid and what infusion rate should be used?
In a 21-year-old woman with systemic lupus erythematosus presenting with heavy proteinuria (~6 g/day), normal serum creatinine, hypertension controlled with antihypertensive medications, moderate-to-severe mitral regurgitation, schistocytes on peripheral smear, low complement C3 and C4, high anti‑double‑stranded DNA antibodies by ELISA, negative antiphospholipid antibody workup, and unavailable ADAMTS13 testing, should cyclophosphamide be chosen instead of rituximab for treatment?
What is the recommended evaluation and treatment for facial nerve palsy that develops after a dental procedure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.